11european life sciences ceo forum · 2018-02-27 · netscienti˚c plc [lon:nsci] anima biotech...
TRANSCRIPT
07:30
08:20
09:15
10:20 Co�ee Break
10:35
11:20
12:15
ResoTher Pharma ApS
Crescendo Biologics Ltd.
IGEM Therapeutics Ltd.
PDC*line Pharma SA
Aurealis Pharma AG
Step Pharma SAS
ATRIVA Therapeutics GmbH
Signia Therapeutics
Adrenomed AG
Forendo Pharma Ltd.
Priavoid GmbH
11:00
11:10
11:20
11:30
11:40
11:50
12:00
12:10
12:20
12:30
12:40
12:50
Registration & Co�ee - Day One, 26th February 2018
Welcome Speech by Leonard Sachs, Managing Director, Sachs Associates
“Going and Being Public: an Interview with Miguel Payró, CFO of GeNeuro SA, Geneva” by Dr. Søren Bjønness, Director – Swiss Representative, EURONEXT
08:30
“Prospects for 2018”- Global Biopharma Industry Review PanelChaired by:Stephanie Léouzon, Principal and Head of Torreya Partners Europe, Torreya Partners (Europe) LLPPanelists:Ari-Pekka Laitsaari, Senior Investment O�cer, European Investment BankChandra Leo, Investment Advisor, HBM Partners AGMark Altmeyer, President & CCO, Axovant SciencesNicholas Franco, EVP & Chief Business Development O�cer, Actelion, a Janssen Pharmaceuticals Company of Johnson & JohnsonNooman Haque, Managing Director, Life Sciences & Healthcare, Silicon Valley Bank
“Latest Trends in Fund Raising and Investment” - Private Equity and VC PanelCo-Chaired by:Annegret de Baey, Venture Partner, Seventure PartnersMarkus Hosang, General Partner, BioMedPartners AGPanelists:Adelaide Cracco, Head of Life Sciences, European Investment FundCharles Kunsch, Director, AbbVie VenturesIain Dukes, Venture Partner, OrbiMed Advisors, LLCOlivier Litzka, Partner, Edmond de Rothschild Investment Partners S.A.S.Tim Haines, Managing Partner, Abingworth LLP
“Capital Raising and Investment Opportunities” - European Equity Capital Markets PanelCo-Chaired by:Chris Maggos, Managing Director, Europe, LifeSci Advisors, LLCPaul Hermant, Partner, Bird & Bird LLPPanelists:Bartjan van Hulten, Founder, Medex CapitalGil Bar-Nahum, Managing Director, Je�eries International LimitedHartmut Ehrlich, CEO, ABIVAXJörg Neermann, Partner, LSPThibaut Roulon, Investment Director, Bpifrance
Neuroscience I – BD&L PanelChaired by:Jennifer Laird, Senior Director, Search & Evaluation, Eli Lilly & CompanyPanelists:Carlos Buesa, CEO & Founder, Oryzon Genomics SAGregor Macdonald, Senior Director, Neuroscience Scienti�c Licensing, Johnson & JohnsonIsabel Ferreira, Director, Global Business Development, F. Ho�mann-La Roche Ltd.Jørgen Drejer, CEO, Saniona ABKlaus Mendla, Global Head of CNS BD&L, Boehringer Ingelheim Pharma GmbH & Co. KG
Neuroscience II – Advanced Therapies and Diagnostics PanelCo-Chaired by:Alexander Breidenbach, Global Head Neuroscience, Ophthalmology & Rare Diseases Partnering,F. Ho�mann-La Roche Ltd.Keno Gutierrez, Investment Director, Merck VenturesPanelists:Declan Jones, VP, Neuroscience Lead, Johnson & Johnson InnovationDirk Beher, CEO, Asceneuron SAGunilla Osswald, President & CEO, BioArctic ABJim DeMesa, CEO, Emerald Health Pharmaceuticals, Inc.Lynn Durham, CEO & Founder, Stalicla SAMichael Almstetter, CEO, Origenis GmbHMichael Scherz, Founder & CEO, Metys Pharmaceuticals AG
EUROPEAN LIFE SCIENCES CEO FORUMSwitzerlandHilton Zurich Airport Hotelth
Partnering and Investing in Biotech & Pharma Industry26 - 27 February 2018th
ANNUAL11
th
09:35
13:00 Networking Lunch
PR Track A - Room BerneModerated by:
Lorenza Castellon, Independent Consultant
BioLingus AG
Room Panorama
Room Panorama
Room Panorama A
Room Panorama A
Room Panorama A
For Wi-Fi Connect to:Honors
Advances in C&G Therapies PanelCo-Chaired by:Alain Vertes, Managing Director, NxR Biotechnologies GmbHZhiZhong Yao, Associate, So�nnova PartnersPanelists:Eric Halioua, President & CEO, PDC*line Pharma SAGabriele Proetzel, Director, Regenerative Medicine, Takeda Pharmaceuticals International AGOlav Hellebo, CEO, ReNeuron Group PLCSarah Holland, Global Head of Licensing, Lonza AGStefanos Theoharis, SVP, Partnering and Corporate Development, Cell MedicaSven Kili, VP & Head of Gene Therapy Development, GlaxoSmithKline
Platform Technologies and Novel Therapeutics PanelChaired by:Nanna Luneborg, Partner, Novo VenturesPanelists:Anker Lundemose, CEO, MISSION Therapeutics Ltd.Christian Jung, Principal, Wellington Partners GmbHHeinz Lubenau, COO, VAXIMM AGJulian Bertschinger, VP, Head Therapeutic Platform Innovation, Janssen Research & Development, LLCOlivier Soula, Deputy General Manager, R&D Director, AdociaYochi Slonim, CEO, Anima Biotech Ltd.
Co�ee Break
16:25
Networking Reception
End of the Networking Reception and Day One
BAYOOMED Medical Software
Origenis GmbH
Upstream Medical Technologies Ltd.
Cellerys AG
Protein Alternatives S.L. (ProAlt)
PR Track E - Room BerneModerated by:
Jørgen Thorball, XOventure GmbH
PR Track B - Room Panorama AModerated by:
Hans Herklots, LifeSci Advisors, LLC
PR Track C - Room Panorama CModerated by:
Sue Charles, Instinctif Partners
PR Track D - Room BerneModerated by:
Wilder Fulford, The Fulford Group Ltd.
Asceneuron SA
Metys Pharmaceuticals AG
Emerald Health Pharmaceuticals, Inc.
Oryzon Genomics SA [BME:ORY]
Saniona AB [STO:SANION]
Stalicla SA
BioArctic AB [STO:BIOA-B]
Addex Therapeutics Ltd. [SWX:ADXN]
ABIVAX [EPA:ABVX]
NetScienti�c PLC [LON:NSCI]
Anima Biotech Ltd.
VAXIMM AG
MOLOGEN AG [ETR:MGN]
Opsona Therapeutics Ltd.
InSphero AG
InCarda Therapeutics, Inc.
MEDICEM Institute S.R.O
Caelus Health
MangoGen Pharma, Inc.
4D Lifetec AG
Dermadis SAS
Imcyse SA
AYOXXA Biosystems GmbH
Lipocalyx GmbH
14:00
13:00
16:15
14:15
14:30
14:45
15:00
15:15
15:30
15:45
Networking Lunch
16:00
17:00
16:15
16:35
16:45
16:55
17:45
20:00
SILVER SPONSORS:
SUPPORTED BY:
Room Panorama A
Room Panorama A
Oncology I – DealMaking PanelCo-Chaired by:Esteban Pombo-Villar, CEO, TargImmune Therapeutics AGMark Krul, Director, Aglaia BioMedical VenturesPanelists:Göran Forsberg, CEO, Cantargia ABHelen Tayton-Martin, CBO, Adaptimmune TherapeuticsKhatereh Ahmadi, Executive Director, Oncology BD&L, MSDMark Vaeck, CEO, Complix NVMatthias Müllenbeck, Director Global Licensing and BD Oncology, Merck KGaAPer Norlén, CEO, Alligator Bioscience ABPeter Pack, CEO, Crescendo Biologics Ltd.
“Key players Focusing on DealMaking to Alliance Management” - Bio-Pharma Partnering PanelChaired by:Fintan Walton, CEO, PharmaVentures Ltd.Panelists:Berthold Hinzen, Head BD&L General Medicine, Bayer HealthCare Pharmaceuticals, LLCConstantine Chinoporos, CBO, Boston Pharmaceuticals, Inc.Isabelle Heit, Director Global Alliance Management, Takeda Pharmaceuticals International AGLubor Gaal, Head of Licensing and External Innovation, Almirall S.A.Patrick Benz, Senior Director Alliance Management, Janssen, Pharmaceutical Companies of Johnson & JohnsonPhil L'Huillier, Head, European Innovation Hub, MSD
"The Future of Personalized Healthcare: The Interplay of Diseases, Information and Technologies" by Miro Venturi, Global Head - Diagnostics Biomarkers, F. Ho�mann-La Roche Ltd.
Co�ee Break
Oncology II – Advanced Therapies and Diagnostics Panel Co-Chaired by: François Thomas, Partner, Inserm Transfert Initiative Tim Herpin, Vice President, Head of Transactions, Business Development, AstraZenecaPanelists:Corinne Danan, EVP, Partnerships BU, HalioDxJuergen Gamer, VP BD, Apogenix AGMichael Bauer, CEO, Cellestia Biotech AGStéphane Degove, CEO, GamaMabs Pharma SAUlrich Kessler, CEO, Inthera Bioscience AG
09:00
09:45
10:05
11:00
11:15
12:00
Early Stage Innovation PanelCo-Chaired by:Holger Schwarz, Director, Global Head of Search & Evaluation Discovery Technologies, Merck KGaAMichèle Ollier, Partner, Medicxi VenturesPanelists:Anja König, Managing Director, Novartis Venture FundDani Bach, Healthcare Investment Director, Touchstone InnovationsErnst Hafen, Director of Studies, ETH Zurich (IMSB)Frauke Hein, CBO, Adrenomed AGNathalie ter Wengel, European Head External R&D and Innovation, P�zer, Inc.Pavithra Sundaresan, Senior Director New Ventures and Transactions, Johnson & Johnson Innovation
PR Track F - Room Panorama CModerated by:
Jørgen Thorball, XOventure GmbH
PR Track G - Room BerneModerated by:
Hans Herklots, LifeSci Advisors, LLC
BRASTER S.A. [BRA:WSE]
IDP Discovery Pharma S.L.
Cellestia Biotech AG
GamaMabs Pharma SA
Cantargia AB [CANTA:FN]
Alligator Bioscience AB [STO:ATORX]
Apogenix AG
EUROPEAN LIFE SCIENCES CEO FORUMSwitzerlandHilton Zurich Airport Hotelth
Partnering and Investing in Biotech & Pharma Industry26 - 27 February 2018th
ANNUAL11
th
08:30
Networking Lunch13:00
Registration & Co�ee - Day Two, 27th February 2018
12:00
12:15
12:30
12:45
SILVER SPONSORS:
SUPPORTED BY:
Room Panorama
Room Panorama
Room Panorama
Room Panorama A
Networking Lunch
Seed Companies Investor RoundtableCo-Chaired by:Dragan Grabulovski, CEO & Founder, Grabulovski Consulting ServicesJeanne Bolger, Vice President, Venture Investments, Johnson & Johnson InnovationPanelists: Alethia de Leon, Managing Director, BaseLaunchChristina Trojel-Hansen, Senior Investment Associate, Novo Holdings A/SFiona MacLaughlin, Director, Inkef CapitalHans-Florian Zeilhofer, Associate Vice President Innovation, University of BaselJakob Busch-Petersen, Intrapreneur, F. Ho�mann-La Roche Ltd.Paul Ashley, Head of Technology Transfer, Oxford University Innovation Ltd.
Rising Stars: Start-Up ShowcaseModerated by:Rao Movva, Pharma and Biotech Advisor & MentorUlrich Muehlner, Co-Founder & CEO, docdok.health AG
Presenting Order:1. Tepthera2. TheraNash Program3. Saverna Therapeutics4. CDR-Life AG5. Araris Biotech AG6. Clemedi7. NovaGo Therapeutics AG
Last Chance to Network - Farewell Reception
End of the ELSCEO Forum
13:00
14:00
15:00
16:00
16:30
SILVER SPONSORS:
SUPPORTED BY:
Room Panorama
Room Panorama
PicoDNAVelox therapeutics8.
9. 10. Prolongate11. REM Analytics12. ABCDx - Advanced Brain Companion Diagnostics13. Dicronis14. docdok.health AG